Tag: Peter Koetsier
Cann Group expects record revenue growth of 111% in FY23
Pharmaceutical company Cann Group Limited announced its FY23 unaudited results, with its operating revenue expected to be approximately $13.5 million, representing growth of 111 per cent or 2.1 times compared to the prior year revenue.
Cann Group names Peter Koetsier as new CEO
Cann Group, a leading manufacturer and supplier of innovative cannabis medicines, appointed Peter Koetsier as its new chief executive officer, effective 16 January 2023.
Featured Article
Australian manufacturing in 2025: Challenges and pathways to progress
The Australian manufacturing sector, long considered the backbone of the nation’s economy, is standing at a crossroads in 2025.
